COMMUNIQUÉS West-GlobeNewswire

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/06/2026
WALTHAM, Mass., June 18, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards
18/06/2026
Global Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc . (Nasdaq: SLSN) a leader in scientifically-driven health care solutions [...]
Teva Submits NDA for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Tourette Syndrome
18/06/2026
NDA submission supported by positive Phase 3 data recently published in JAMA Neurology. Ecopipam is a first-in-class selective dopamine D1 receptor antagonist with a novel mechanism of action and has received FDA Orphan [...]
Vireo Growth Inc. Completes Acquisition of Equity Interest in Maryland Dispensaries
18/06/2026
MINNEAPOLIS, June 18, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOD) (“Vireo” or the “Company”), today announced the closing of its previously announced acquisition to acquire an indirect 49% [...]
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/06/2026
FOSTER CITY, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective June 17, 2026, it granted stock options to purchase [...]
Memento Medicines Launches with $93 Million Series A Financing to advance Tie2 Agonist and VEGF Inhibitor Bispecific Antibody Therapy for Retinal Diseases
18/06/2026
Lead program, MMT-205, licensed from MabTics Co., Ltd / Curacle Co., Ltd. is a potential best-in-class bispecific antibody which activates Tie2 and inhibits VEGF, in development for neovascular age-related macular [...]
CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity
18/06/2026
CHICAGO, June 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that its wholly owned [...]
Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET
18/06/2026
TEL AVIV, Israel and PARSIPPANY, N.J., June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2026 financial [...]
Autonomix Announces Reverse Stock Split
18/06/2026
THE WOODLANDS, TX, June 18, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
Hi*Ball Energy fait son entrée au Royaume-Uni et redéfinit les codes de la boisson énergisante
18/06/2026
Faites le plein d’énergie autrement avec Hi*Ball Sparkling Energy Water, une boisson pétillante énergisante qui se veut audacieuse et sans compromis, composée de caféine naturelle et d’ingrédients fonctionnels, sans [...]
Teva Releases Q2 2026 Aide Memoire
18/06/2026
TEL AVIV, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q2 2026 Aide Memoire is available on the “Investors” page on its website. Q2 2026 [...]
TestWell Launches Personalized Lab Testing Platform with Custom Test Selection and Physician Integration
18/06/2026
Company Introduces Flexible Direct to Consumer Testing Platform with Custom Panels and Physician Sharing Tools FORT LAUDERDALE, Florida, June 18, 2026 (GLOBE NEWSWIRE) -- TestWell, a direct to consumer laboratory [...]
Constantiam Biosciences and Cincinnati Children’s Collaborate to Accelerate First-in-Class Neuronopathic Gaucher Disease Therapies
18/06/2026
WATERTOWN, Mass. and CINCINNATI, June 18, 2026 (GLOBE NEWSWIRE) -- Constantiam Biosciences and Cincinnati Children's today announced a strategic collaboration through an exclusive option for future licensing rights to [...]
CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
18/06/2026
BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today announced that it has [...]
Music Beats Cancer Hosts BreakthroughLive – The After Party at BIO 2026, Bringing Together Biotech Innovation and Music to Advance the Fight Against Cancer
18/06/2026
SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Music Beats Cancer, the nonprofit organization dedicated to accelerating cancer innovation through music, community, and philanthropy, will host BreakthroughLive – The After [...]
Diazyme Laboratories, Inc. Announces FDA 510(k) Clearance for Lipoprotein(a) Molarity Assay
18/06/2026
POWAY, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Diazyme Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Diazyme Lipoprotein(a) Molarity Assay. [...]
FamilyWell Health Launches Menopause Hub, Setting the Standard for Behavioral Health in Midlife Care
18/06/2026
Program introduces free clinical guidelines for women’s health providers and a comprehensive behavioral health certification for coaches and clinicians BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- FamilyWell Health , the [...]
New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)
18/06/2026
MIAMI, June 18, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, [...]
BiomX Provides Update on Defense Technology Portfolio and Growth Strategy
18/06/2026
Presentation reflects BiomX’s completed strategic transition and current focus on technologies that identify, analyze, and respond to physical threats NETANYA, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE [...]

Pages